Equity and capacity to benefit from early access to medicines schemes
Abstract Many diseases, especially rare ones, have not gained the attention or support needed to attract dedicated research interest to be able to develop successful medicines. There is, thus, a significant unmet clinical need, not all of which is (or indeed can be) addressed through the evaluation...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-04-01
|
| Series: | International Journal for Equity in Health |
| Online Access: | https://doi.org/10.1186/s12939-025-02416-3 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|